Rong Xu

No ORCID on file · 3 papers in corpus
2024
Combined hepatocellular-cholangiocarcinoma and hepatocellular carcinoma: Differentiation using radiomics based on Multitemporal CT images
·doi:10.21203/rs.3.rs-3930933/v1

Abstract Purpose: To investigate the value of radiomics in differentiating combined hepatocellular-cholangiocarcinoma (cHCC-CCA) and hepatocellular carcinoma (HCC). Materials and Methods: We retrospectively collected the clinical, serum bi…

2024
GLP-1 Receptor Agonists and Risk of Paralytic Ileus: A drug-target Mendelian Randomization Study
·doi:10.1101/2024.10.17.24315627

Background Paralytic ileus (PI), a condition characterized by reduced bowel motor activity without physical obstruction, can be affected by complications from type 2 diabetes (T2D) and anti-diabetic medications. It is unclear of the causal …

2022
Oncometabolite D-2-hydroxyglutarate - dependent metabolic reprogramming induces skeletal muscle atrophy during cancer cachexia
·doi:10.21203/rs.3.rs-1246702/v1

Abstract Cancer cachexia is characterized by weight loss and skeletal muscle wasting. Based on the up-regulation of catabolism and down-regulation of anabolism, cachexia-associated metabolites and oncometabolites can accumulate in cancer p…